"Harvard University and I have settled our ongoing litigation regarding the allocation of royalties related to the license with Tetraphase Pharmaceuticals on mutually agreeable terms. In light of my claims and goals in bringing this litigation, I am very pleased to accept terms I view as equitable.”Full link to press release here and here. Background to the story here and here.
Friday, June 24, 2016
Charest v. Harvard settled
From the inbox, a press release from Dr. Mark Charest, a former graduate student with Professor Andy Myers at Harvard: